These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 867013)

  • 21. Effect of saralasin in hypertensive patients on chronic hemodialysis.
    Lifschitz MD; Kirschenbaum MA; Rosenblatt SG; Gibney R
    Ann Intern Med; 1978 Jan; 88(1):23-7. PubMed ID: 619754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical usefulness of saralasin in human hypertension (author's transl)].
    Fouchard M; Bichara M; Grüfeld JP; Barbanel C; Meyer P; Funck-Brentano JL
    Nouv Presse Med; 1978 Feb; 7(7):539-43. PubMed ID: 643579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-uraemic chronic renal disease.
    Brod J; Bahlmann J; Cachovan M; Hubrich W; Pretschner D
    Nephron; 1980; 25(4):167-72. PubMed ID: 6990284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A; Deschodt G; Barjon P; Mary H; Thevenet A
    Nouv Presse Med; 1978 Dec; 7(43):3889-93. PubMed ID: 733540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis.
    Sørensen SS; Danielsen H; Jespersen B; Pedersen EB
    Clin Nephrol; 1986 Dec; 26(6):288-96. PubMed ID: 3802595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous angiotensin II facilitates sympathetically mediated hemodynamic responses in pithed rats.
    Kaufman LJ; Vollmer RR
    J Pharmacol Exp Ther; 1985 Oct; 235(1):128-34. PubMed ID: 3900340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
    Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hemodynamic changes after angiotensin II blockade by saralasin (author's transl)].
    Liebau G; Beyer J; Larbig D; Schick K; Sekanina G; Hayduk K
    Klin Wochenschr; 1977 Jul; 55(13):647-9. PubMed ID: 19645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overhydratation and renin in hypertensive patients with terminal renal failure: a hemodynamic study.
    Safar ME; London GM; Weiss YA; Milliez PL
    Clin Nephrol; 1975 Nov; 4(5):183-8. PubMed ID: 1192620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemodynamic effects of sar1-ala8-angiotensin in patients with renovascular hypertension (author's transl)].
    Philipp T; Zschierdrich H; Distler A
    Klin Wochenschr; 1977 Sep; 55(18):917-9. PubMed ID: 916618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].
    Klaus D; Witzgall H; Zehner J; Dürr H; Lange H
    Dtsch Med Wochenschr; 1976 Sep; 101(37):1357-9. PubMed ID: 954592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of saralasin in end-stage renal disease.
    Fadem SZ; Lifschitz MD
    Kidney Int Suppl; 1979 Mar; (9):S93-100. PubMed ID: 289869
    [No Abstract]   [Full Text] [Related]  

  • 35. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
    Brunner HR; Gavras H; Ribeiro AB; Posternak L
    Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
    Arroyo V; Bosch J; Mauri M; Ribera F; Navarro-López F; Rodés J
    Eur J Clin Invest; 1981 Jun; 11(3):221-9. PubMed ID: 6791942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subpressor doses of angiotensin II do not increase albumin excretion in humans.
    Erley CM; Grau C; Furian TC; Wolf S; Braun N; Risler T
    Clin Nephrol; 1996 Nov; 46(5):312-8. PubMed ID: 8953120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of high sodium intake and angiotensin antagonist in rabbits with severe and moderate hypertension induced by constriction of one renal artery.
    Romero JC; Holmes DR; Strong CG
    Circ Res; 1977 May; 40(5 Suppl 1):I17-23. PubMed ID: 870227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of saralasin on 20 hypertensive patients (author's transl)].
    Plaza de los Reyes M; Passalacqua W; Plaza de los Reyes X; Pla C; Campino C
    Rev Med Chil; 1980 Feb; 108(2):115-20. PubMed ID: 7017869
    [No Abstract]   [Full Text] [Related]  

  • 40. The hypertension of long-term hemodialysis patients: studies with an angiotensin II antagonist (P113).
    Mimran A; Shaldon S; Mathieu MN; Polito C; Barjon P; Mion C
    Trans Am Soc Artif Intern Organs; 1976; 22():9-13. PubMed ID: 951896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.